Healthy Extracts Inc. (HYEX)
OTCMKTS
· Delayed Price · Currency is USD
2.350
+0.126 (5.67%)
At close: Feb 20, 2026
Healthy Extracts Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2018 |
| Revenue | 3.59 | 3.11 | 2.49 | 2.25 | 1.68 | 1.28 | Upgrade
|
| Revenue Growth (YoY) | 19.20% | 25.24% | 10.41% | 34.29% | 31.34% | 70.58% | Upgrade
|
| Cost of Revenue | 1.71 | 1.2 | 0.86 | 0.88 | 0.98 | 1.86 | Upgrade
|
| Gross Profit | 1.88 | 1.91 | 1.62 | 1.37 | 0.7 | -0.58 | Upgrade
|
| Selling, General & Admin | 2.75 | 2.09 | 3.87 | 2.28 | 2.54 | 1.43 | Upgrade
|
| Operating Expenses | 2.75 | 2.09 | 3.87 | 2.28 | 2.54 | 1.43 | Upgrade
|
| Operating Income | -0.87 | -0.18 | -2.24 | -0.91 | -1.84 | -2.01 | Upgrade
|
| Interest Expense | -0.17 | -0.19 | -0.18 | -0.06 | -0.05 | -0.07 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.13 | -0.47 | -0.05 | -0.01 | -0.13 | 1.01 | Upgrade
|
| EBT Excluding Unusual Items | -1.17 | -0.84 | -2.47 | -0.99 | -2.03 | -1.07 | Upgrade
|
| Impairment of Goodwill | - | - | - | - | - | -1.58 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | 0 | - | - | Upgrade
|
| Other Unusual Items | - | - | - | - | 0.04 | 0.08 | Upgrade
|
| Pretax Income | -1.17 | -0.84 | -2.47 | -0.98 | -1.99 | -2.58 | Upgrade
|
| Earnings From Continuing Operations | -1.17 | -0.84 | -2.47 | -0.98 | -1.99 | -2.58 | Upgrade
|
| Net Income | -1.17 | -0.84 | -2.47 | -0.98 | -1.99 | -2.58 | Upgrade
|
| Net Income to Common | -1.17 | -0.84 | -2.47 | -0.98 | -1.99 | -2.58 | Upgrade
|
| Shares Outstanding (Basic) | 6 | 3 | 3 | 3 | 3 | 2 | Upgrade
|
| Shares Outstanding (Diluted) | 6 | 3 | 3 | 3 | 3 | 2 | Upgrade
|
| Shares Change (YoY) | 96.42% | 2.17% | 2.14% | 7.30% | 34.52% | 114.53% | Upgrade
|
| EPS (Basic) | -0.20 | -0.28 | -0.85 | -0.34 | -0.75 | -1.30 | Upgrade
|
| EPS (Diluted) | -0.20 | -0.28 | -0.85 | -0.34 | -0.75 | -1.30 | Upgrade
|
| Free Cash Flow | -0.18 | 0.28 | -0.42 | -0.4 | -0.9 | -1.9 | Upgrade
|
| Free Cash Flow Per Share | -0.03 | 0.10 | -0.14 | -0.14 | -0.34 | -0.96 | Upgrade
|
| Gross Margin | 52.37% | 61.39% | 65.24% | 60.92% | 41.46% | -45.31% | Upgrade
|
| Operating Margin | -24.20% | -5.88% | -90.26% | -40.49% | -109.89% | -157.60% | Upgrade
|
| Profit Margin | -32.71% | -27.00% | -99.48% | -43.67% | -118.52% | -201.82% | Upgrade
|
| Free Cash Flow Margin | -5.02% | 9.06% | -16.73% | -17.70% | -53.76% | -149.05% | Upgrade
|
| EBITDA | -0.87 | -0.18 | -2.24 | -0.91 | -1.84 | -2 | Upgrade
|
| EBITDA Margin | -24.16% | -5.86% | -90.18% | -40.45% | -109.58% | -156.90% | Upgrade
|
| D&A For EBITDA | 0 | 0 | 0 | 0 | 0.01 | 0.01 | Upgrade
|
| EBIT | -0.87 | -0.18 | -2.24 | -0.91 | -1.84 | -2.01 | Upgrade
|
| EBIT Margin | -24.20% | -5.88% | -90.26% | -40.49% | -109.89% | -157.60% | Upgrade
|
| Revenue as Reported | 3.59 | 3.11 | 2.49 | 2.25 | 1.68 | 1.28 | Upgrade
|
| Advertising Expenses | - | 0.7 | - | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.